Citations

Clear

47 citation(s) found for "Scanlon, P D".

C108-06 Application of Global Lung Function Initiative DLCO Predictive Equations in a Large Multicenter Pulmonary Function Laboratory Population
Farah, W H, Subat, Y, Liu, E, Kanj, A N, Scanlon, P D, Niven, A S, Subat, Yosuf W., Kanj, A.N., Scanlon, Paul D.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.5462 Get It

Abstract Background Single breath diffusing capacity of the lung for carbon monoxide (DLCO) remains the most widely used test to assess pulmonary gas exchange. GLI DLCO reference equations are based on a larger, more diverse dataset and offer age-specific and internally consistent reference values. However, their impact on interpretation in a real-world population remains uncertain. Research Question Describe the direction and magnitude of DLCO interpretation changes resulting from our multicenter PFT laboratory transition from Miller to GLI reference equations. Study Design and Methods In this multicenter cross-sectional study, we reanalyzed 88,060 DLCO measurements in a large pulmonary function laboratory database performed between 2016 and 2022 using GLI and Miller reference equations, stratified by self-reported race and ethnicity. Baseline patient characteristics and lung function measurements were summarized with continuous characteristics as median (IQR) and categorical variables as n (%). Kruskal-Wallis test was used to evaluate the difference between GLI and Miller DLCO % predicted difference between races, and two-by-two and four-by-four tables were generated to summarize the proportion of concordance and discordance of GLI to Miller severity levels. A repeated measures multivariable logistic regression was used to evaluate discordance between GLI and Miller severity and patient characteristics (age, sex, race, and BMI). Results We included 63,357 individuals with 88,060 PFT visits; 91.6% (58,076) identified as Caucasian, 5.2% (3,262) as Black, 1.4 % (895) as Asian, and 1.8% (1,113) as mixed/other race. Fifty-one percent were female with an median age of 64 years (range: 5- 85). 7.4% (6509) of DLCO results were discordant, with 0.5% (n = 439) abnormal by GLI only, and 6.9% (n = 6070) abnormal by Miller only. Compared to the Miller, GLI interpretations were associated with a greater shift toward normal interpretations. Younger age, lower BMI, female sex, and being of NE Asian, SE Asian, or Other/mixed race compared to Caucasian were associated with higher odds of discordance in DLCO severity/normal classification. Interpretation The use of GLI reference equations substantially alters the interpretation of DLCO results, shifting a meaningful subset of patients from abnormal to normal classification. While GLI reference equations offer more comprehensive, population-based approach, it is crucial to place these interpretations within the context of the patient presentation until further investigations more clearly define the clinical implications of these transitions. This abstract is funded by: none
Exhaled Nitric Oxide Before and After Spirometry
Mottram, Carl, Dicke, Rosemary, Hynes, Katrina M, Scanlon, Paul D.

Mayo Clinic

Respiratory Care | March 12, 2026 | Volume: 63 | Issue: 10_suppl | Pages: 3020139-3020139

10.4187/respcare.20183020139 Get It

P11.14.A STEREOTACTIC RADIOSURGERY FOR OVARIAN CANCER BRAIN METASTASES: AN INTERNATIONAL RADIOSURGERY RESEARCH FOUNDATION RETROSPECTIVE STUDY
Mathieu, D, Billau, Mathilde Djeneba, Adam, Elizabeth , Iorio‐Morin, Christian , Liscak, R, Niranjan, A, Wei, Zheng , Lunsford, L. Dade , José, São, Scanlon, Samantha, Silverman, Joshua B., Mullen, Russell , Bernstein, Kenneth , Samanci, Yavuz, Düzkalır, Ali Haluk , Phuong, Christina , Sheehan, Jason , Pikis, Styllianos, Kosyakovsky, Jacob, Prasad, Rajendra , Cifarelli, Daniel T. , Icaza, Denisse Arteaga, Wegner, Rodney E. , Shepard, M J, Bowden, Greg , Wandrey, Narine , Rusthoven, Chad G. , Hintz, Eric , Schulder, Michael , Goenka, Anuj , Peterson, Jeffrey J., Mathieu, David , Hamel, Andréanne, Liscak, R, May, Jaromír , Niranjan, A, Wei, Z, Luy, Diego D. , Silverman, J, Kondziolka, Douglas , Peker, Selçuk , Samancı, Yavuz , Braunstein, Steve , Prasad, R N, Palmer, Joshua D. , Bailey, D, Zacharia, Brad E. , Cifarelli, Christopher P.

Mayo Clinic

Neuro-Oncology | October 3, 2025 | Volume: 27 | Issue: Supplement_3 | Pages: iii106-iii106

10.1093/neuonc/noaf193.353 Get It

Abstract BACKGROUND Ovarian cancer rarely metastasises to the brain, thus studies reporting the outcomes of affected patients are lacking. Stereotactic radiosurgery (SRS) is now the mainstay of management for patients with brain metastases (BM) from most primary sites, but little evidence of its efficacy in ovarian cancer is available. The current study was undertaken to provide guidance for SRS management using pooled data from multiple institutions. MATERIAL AND METHODS Centers participating in the IRRF (International Radiosurgery Research Foundation) were asked to provide outcome data for patients who had SRS for ovarian cancer brain metastases between 2020 and 2024 and at least one clinical and imaging follow-up after the procedure. Primary endpoints included survival from SRS, local tumor response according to RANO-BM criteria and occurrence of adverse radiation effects (ARE). Cox regression analyses were performed to identify variables impact each endpoint. RESULTS 128 patients had SRS for a total of 532 BM treated. Epithelial histology was the most common (91%). Median age at SRS was 62 years (IQR 56-70). Median KPS was 80% (IQR 80-90%) and 71.9% of patients had neurological symptoms at presentation. Other active systemic metastases were present in 41.4%. The median number of treated BM was 2 (IQR1-3) and the median cumulative treatment volume was 6 cc (IQR 2-12.9). The median margin dose was 18 Gy (IQR 16-20). At last follow-up, 19.5% of patients were still alive. The median overall survival (OS) after SRS was 27 months, and 6-, 12- and 24-month OS was 83.8%, 74.2% and 52.2%, respectively. Multivariate analyses revealed that increasing age at SRS (HR 1.02, p=0.05), active systemic metastases (HR 2, p=0.005) and increasing number of brain metastases (HR 1.05, p=0.04) were associated with worse survival, while repeating SRS (HR 0.4, p=0.002) led to improved survival. Local failure occurred in 12.8% of treated BM. Actuarial progression-free survival (PFS) at 6, 12 and 24 months was 92.3%, 86.6% and 70.3%, respectively. Only prior WBRT (HR 4.36, p=0.03) led to worse local control on multivariate analyses. New remote BM appeared in 49.5% of patients and 14.5% suffered from leptomeningeal dissemination. ARE were seen in 12.1% of BM but were symptomatic in only 3.2%. On multivariate analyses, prior SRS (HR 3.13, p=0.002) was associated with increased risk of ARE. CONCLUSION Ovarian cancer brain metastases can be safely and effectively managed with SRS as the primary treatment modality in most patients.
Supporting cancer research on real-world data: extracting colorectal cancer status and explicitly written TNM stages from free-text imaging and histopathology reports
Tamm, Andres , Jones, Helen , Doshi, Neel , Perry, William , Withers, Joshua, Salih, Hizni , Noble, Theresa , Little, Stephanie , Roadknight, Gail , Campell, D.J., Matharu, Sheila, Teare, Marion, Galdikas, A., Papadimitriou, Dimitri , Scanlon, Lauren , Woods, Kerrie , Cunningham, Chris , Roadknight, Gail , Perry, William R , Várnai, Kinga A. , Matharu, Sheila, Starling, Naureen , Teare, Marion, Galdikas, Algirdas, Glampson, Ben , Mercuri, Luca , Wasan, Harpreet , Malcomson, Lee , O’Hara, Catherine M. , Renehan, Andrew G. , Nicholson, Brian D , Davies, Jim , Morris, Eva J.A. , Cunningham, Chris

Mayo Clinic

BMJ Health & Care Informatics | September 22, 2025 | Volume: 32 | Issue: 1 | Pages: e101521

10.1136/bmjhci-2025-101521 | PMID 40983364 Get It

Objectives The ‘tumour, node, metastasis’ (TNM) classification of colorectal cancer (CRC) predicts prognosis and so is vital to consider in analyses of patterns and outcomes of care when using electronic health records. Unfortunately, it is often only available in free-text reports. This study aimed to develop regex-based text-processing algorithms that identify the reports describing CRC and extract the TNM staging at a low computational cost. Methods The CRC and TNM extraction algorithms were iteratively developed using 58 634 imaging and pathology reports of patients with CRC from the Oxford University Hospitals (OUH) and Royal Marsden (RMH) NHS Foundation Trusts (FT), with additional input from Imperial College Healthcare and Christie NHS FTs. The algorithms were evaluated on a stratified random sample of 400 OUH development data reports and 400 newer ‘unseen’ OUH reports. The reports were annotated with the help of two clinicians. Results The CRC algorithm achieved at least 93.0% positive predictive value (PPV), 72.1% sensitivity, 64.0% negative predictive value (NPV) and 90.1% specificity for primary CRC on pathology reports. On imaging reports, it demonstrated at least 78.0% PPV, 91.8% sensitivity, 93.0% NPV and 80.9% specificity. For the main T/N/M categories, the TNM algorithm achieved PPVs of at least 93.9% (T), 97.7% (N) and 97.2% (M), and sensitivities of 63.6% (T), 89.6% (N) and 64.8% (M). NPVs were at least 45.0% (T), 91.1% (N), 88.4% (M), and specificities 95.7% (T), 98.1% (N), 99.3% (M). Reductions in performance were mostly due to implicit staging. For extracting explicit TNM stages, current or historical, the algorithm made no errors on 400 pathology reports and six errors on 400 imaging reports. Conclusion The TNM algorithm accurately extracts explicit TNM staging, but other methods are needed for retrieving implicit stages. The CRC algorithm is accurate on non-supplementary reports, but outputs need additional review if higher precision is required.
Multicenter Retrospective Study of Stereotactic Radiosurgery for Gynecological Cancer Brain Metastases
Billau, Mathilde Djeneba, Hamel, Andréanne, Tourigny, Jean-Nicolas, Iorio‐Morin, Christian , Niranjan, Ajay , Wei, Zhishuo , Lunsford, L. Dade , Jose, Shalini, Scanlon, Sydney, Mullen, Reed, Bernstein, Kenneth , Phuong, Christina , Sheehan, Jason P. , Pikis, Stylianos , Kosyakovsky, Jacob, Prasad, Rahul N. , Icaza, Denisse Arteaga, Cifarelli, Daniel T. , Wegner, Rodney E. , Shepard, Matthew J., Bowden, Gregory, Wandrey, Narine , Rusthoven, Chad G. , Hintz, Eric , Schulder, Michael , Goenka, Anuj , Peterson, Jennifer , Mathieu, David , Liščák, Roman , May, Jaromír , Luy, Diego D. , Silverman, Joshua S. , Kondziolka, Douglas , Peker, Selçuk , Samancı, Yavuz , Braunstein, Steve , Palmer, Joshua D. , Bailey, David, Zacharia, Brad E. , Cifarelli, Christopher P. , Mathieu, David

Mayo Clinic

Neurosurgery | July 7, 2025 | Volume: 98 | Issue: 1 | Pages: 194-203

10.1227/neu.0000000000003609 | PMID 40622139 Get It

BACKGROUND AND OBJECTIVES: Gynecological cancers represent 10% to 15% of cancers in women, but brain metastases (BM) are uncommon, with limited evidence regarding their management. This study investigates the role of stereotactic radiosurgery (SRS) for BM from primary gynecological cancers. METHODS: Institutions of the International Radiosurgery Research Foundation participated in this study. Inclusion criteria required histological diagnosis of epithelial ovarian, cervical, or endometrial cancer, SRS between 2000 and 2020, and at least 1 imaging or clinical follow-up. RESULTS: A total of 276 patients having SRS for 977 BM were included. Median age at SRS was 62 years (IQR, 55-70). Primary cancer origin was ovarian in 128 (46%), cervical in 43 (16%), and endometrial in 105 patients (38%). Median Karnofsky Performance Scale was 80%, and systemic disease was active in 124 (45%) of patients. A median of 1 metastasis was treated (IQR, 1-3) per patient. Median individual metastasis volume was 0.27 cc (IQR, 0.05-1.59 cc). The majority (91%) received single-fraction SRS, using a median margin dose of 18 Gy (IQR, 16-20 Gy). Actuarial overall survival was 77%, 65%, and 44% at 6, 12, and 24 months, respectively. Predictors of worsened survival included older age, cervical and endometrial primary, previous whole-brain radiation therapy (WBRT), active systemic disease, worsened Karnofsky Performance Scale, absence of subsequent surgery, and increasing number of BM. Actuarial local control was 94% at 6 months, 89% at 12 months, and 78% at 24 months. Previous SRS or WBRT, tumor bed treatment, and cervical histology increased the risk of local failure. New remote BM and leptomeningeal dissemination occurred in 44% and 11% of patients, respectively. Adverse radiation effects (ARE) occurred in 13% of cases but were symptomatic in only 3%. Previous WBRT or SRS and increased tumor diameter increased the risk of ARE. CONCLUSION: SRS is an effective management for BM from gynecological cancers with low risks of symptomatic ARE.
Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population
Scanlon, Paul D., Yadav, Hemang , Smith, William T., Herzog, Tyler L. , Bungum, Aaron O., Poliszuk, Daniel, Fick, E., Lee, Augustine S. , Niven, Alexander S. , Yadav, Hemang , Niven, Alexander S , Kanj, Amjad

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | July 31, 2023 | Volume: 209 | Issue: 1 | Pages: 83-90

10.1164/rccm.202303-0613oc | PMID 37523681 Get It

Abstract Rationale Global Lung Function Initiative (GLI) Global spirometry reference equations were recently derived to offer a “race-neutral” interpretation option. The impact of transitioning from the race-specific GLI-2012 to the GLI Global reference equations is unknown. Objectives Describe the direction and magnitude of changes in predicted lung function measurements in a population of diverse race and ethnicity using GLI Global in place of GLI-2012 reference equations. Methods In this multicenter cross-sectional study using a large pulmonary function laboratory database, 109,447 spirometry tests were reanalyzed using GLI Global reference equations and compared with the existing GLI-2012 standard, stratified by self-reported race and ethnicity. Measurements and Main Results Mean FEV1 and FVC percent predicted increased in the White and Northeast Asian groups and decreased in the Black, Southeast Asian, and mixed/other race groups. The prevalence of obstruction increased by 9.7% in the White group, and prevalences of possible restriction increased by 51.1% and 37.1% in the Black and Southeast Asian groups, respectively. Using GLI Global in a population with equal representation of all five race and ethnicity groups altered the interpretation category for 10.2% of spirometry tests. Subjects who self-identified as Black were the only group with a relative increase in the frequency of abnormal spirometry test results (32.9%). Conclusions The use of GLI Global reference equations will significantly impact spirometry interpretation. Although GLI Global offers an innovative approach to transition from race-specific reference equations, it is important to recognize the continued need to place these data within an appropriate clinical context.
Application of GLI Global Spirometry Reference Equations to a Large Population Across a Multi-site Academic Healthcare System
Scanlon, Paul D., Bungum, Aaron O., Poliszuk, D., Fick, E., Smith, W.T., Herzog, Thomas J. , Kanj, Amjad , Niven, Alexander S.

Mayo Clinic

B30. BREATHE (IN THE AIR): STUDIES IN PULMONARY FUNCTION | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A3008-A3008

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3008 Get It

Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
Scanlon, Erin M. , Mankad, Rekha , Davis, John M. , Scanlon, Erin M.

Mayo Clinic

EMJ Rheumatology | April 11, 2023 | Volume: No volume available | Issue: No issue available | Pages: 106-113

10.33590/emjrheumatol/10313865 Get It

People with rheumatoid arthritis (RA) are often under-recognised as a group with elevated risk of cardiovascular (CV) disease and increased morbidity from CV events. Standard clinical risk assessment tools, which take into account traditional CV risk factors such as smoking, diabetes, hypertension, hyperlipidaemia, and family history do not accurately predict CV risk in patients with autoimmune rheumatic disorders; therefore, there is an unmet need for other methods to assess their risk. Non-invasive CV imaging is evolving as a novel clinical tool to determine subclinical atherosclerotic coronary artery disease in patients with RA. Non-invasive imaging studies, such as tests of endothelial function (i.e. reactive hyperaemia index and flow-mediated dilation) and arterial stiffness (i.e. pulse-wave velocity), have been identified as a potential means for providing accurate assessment of early CV risk in the general population and are evolving in their utility for patients with RA. These types of non-invasive imaging have the potential to eliminate the current use of invasive assessments for identification of precursors to coronary artery disease, such as coronary angiography for early endothelial cell dysfunction. By combining the expertise of subspecialists in cardio-rheumatology clinics, the expectation is to pre-emptively identify RA patients with early coronary artery disease, allowing early modification of risk factors through either medical management or lifestyle modification.
Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing
Subat, Yosuf W., Meyer, Todd J., Torgerud, Keith D, Scanlon, Paul D., Lim, Kaiser G. , Niven, Alexander S.

Mayo Clinic

Respiratory Care | May 24, 2022 | Volume: 67 | Issue: 8 | Pages: 899-905

10.4187/respcare.09703 | PMID 35610032 Get It

BACKGROUND: Methacholine challenge testing (MCT) is a common bronchoprovocation technique used to assess airway hyper-responsiveness. We previously demonstrated that the addition of a viral filter to the nebulizer exhalation limb substantially reduced expelled particles during MCT. Our aim was to evaluate whether this modification affects the delivered dose of methacholine. METHODS: A mechanical ventilator was connected to a lung simulator with breathing frequency 15 breaths/min, tidal volume 500 mL, inspiratory-expiratory ratio 1:1, with a sinusoidal waveform. We compared methacholine dose delivery using the Hudson Micro Mist or AeroEclipse II BAN nebulizers powered by either a dry gas source or a compressor system. A filter placed in line between the nebulizer and test lung was weighed before and after 1 min of nebulized methacholine delivery. Mean inhaled mass was measured with and without a viral filter on the exhalation limb. Dose delivery was calculated by multiplying the mean inhaled mass by the respirable fraction (particles < 5 μm) and inhalation time. Unpaired t test was used to compare methacholine dose delivery with and without viral filter placement. RESULTS: The addition of a viral filter did not significantly affect methacholine dose delivery across all devices tested. Using a 50-psi dry gas source, dose delivered with or without a viral filter did not differ with the Hudson (422.3 μg vs 282.0 μg, P = .11) or the AeroEclipse nebulizer (563.0 μg vs 657.6 μg, P = .59). Using the compressor, dose delivered with and without a viral filter did not differ with the Hudson (974.0 μg vs 868.0 μg, P = .03) or the AeroEclipse nebulizer (818.0 μg vs 628.5 μg, P = .42). CONCLUSIONS: The addition of a viral filter to the nebulizer exhalation limb did not affect methacholine dose during bronchoprovocation testing. Routine use of a viral filter should be considered to improve pulmonary function technician safety and infection control measures during the ongoing COVID-19 pandemic.
Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19
Subat, Yosuf W., Hainy, Matthew E, Torgerud, Keith D, Sajgalik, Pavol , Guntupalli, Siva Kamal, Johnson, Bruce D. , Kim, Chul‐Ho , Scanlon, Paul D., Chul-Ho, Kim, Lim, Kaiser G. , Helgeson, Scott A. , Niven, Alexander S.

Mayo Clinic

Respiratory Care | November 17, 2021 | Volume: 66 | Issue: 12 | Pages: 1858-1865

10.4187/respcare.09236 | PMID 34789516 Get It

BACKGROUND: Methacholine bronchoprovocation or challenge testing (MCT) is commonly performed to assess airway hyper-responsiveness in the setting of suspected asthma. Nebulization is an aerosol-generating procedure, but little is known about the risks of MCT in the context of the ongoing coronavirus disease 2019 (COVID-19) pandemic. We aimed to quantify and characterize aerosol generation during MCT by using different delivery methods and to assess the impact of adding a viral filter. METHODS: Seven healthy subjects performed simulated MCT in a near particle-free laboratory space with 4 different nebulizers and with a dosimeter. Two devices continuously sampled the ambient air during the procedure, which detected ultrafine particles, from 0.02–1 μm, and particles of sizes 0.3, 0.5, 1.0, 2.0, 5.0, and 10 µm, respectively. Particle generation was compared among all the devices, with and without viral filter placement. RESULTS: Ultrafine-particle generation during simulated MCT was significant across all the devices. Ultrafine-particle (0.02–1 μm) concentrations decreased 77%–91% with the addition of a viral filter and varied significantly between unfiltered (P < .001) and filtered devices (P < .001). Ultrafine-particle generation was lowest when using the dosimeter with filtered Hudson nebulizer (1,258 ± 1,644 particle/mL). Ultrafine-particle concentrations with the filtered nebulizer devices using a compressor were higher than particle concentrations detected when using the dosimeter: Monaghan (3,472 ± 1,794 particles/mL), PARI (4,403 ± 2,948), Hudson (6,320 ± 1,787) and AirLife (9,523 ± 5,098). CONCLUSIONS: The high particle concentrations generated during MCT pose significant infection control concerns during the COVID-19 pandemic. Particle generation during MCT was significantly reduced by using breath-actuated delivery and a viral filter, which offers an effective mitigation strategy.